Form 6-K BioLineRx Ltd. For: May 27

Go back to Form 6-K BioLineRx Ltd. For: May 27

Jones Trading Reiterates Hold Rating on BioLineRx (BLRX)

May 28, 2025 8:59 AM EDT

Jones Trading analyst Justin Walsh reiterated a Hold rating on BioLineRx (NASDAQ: BLRX).

The analyst comments "APHEXDA will provide a steady stream of royalties that support earlier stage development of assets expected to be in-licensed in 2025-2026, most likely in the oncology and/or... More